• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Dermatol Ther. Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): a brief review

tetano

Editor, Senior Moderator
Dermatol Ther. 2020 May 7. doi: 10.1111/dth.13528. [Epub ahead of print]
Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): a brief review.


Tang K[SUP]1,[/SUP][SUP]2[/SUP], Wang Y[SUP]1,[/SUP][SUP]2[/SUP], Zhang H[SUP]1,[/SUP][SUP]2[/SUP], Zheng Q[SUP]1,[/SUP][SUP]2[/SUP], Fang R[SUP]1[/SUP], Sun Q[SUP]1[/SUP].

Author information




Abstract

COVID-19, first appeared in December 2019 in Wuhan, China, has been spreading quickly throughout the world. We reviewed the evidence on cutaneous manifestations of COVID-19 based on PubMed database. The searching strategy was (COVID* or coronavirus*) and (dermatol* or skin* or cutaneous*). The publication time was limited to 2019 onward. After independent review by two authors, 14 studies with 228 confirmed cases were included in the analysis. A total of 60 patients developed skin rashes, and the age ranged from 8 to 84. Exanthematous eruptions potentially related to COVID-19 infection were highly variable and heterogeneous. Skin lesions mainly appeared erythematous, urticarial, and vesicular (chicken pox-like or varicelliform). Petechiae rash, livedo reticularis, and reactivation of oral HSV-1 were also observed in single cases. Newly reported eruptions like vascular lesions and peculiar (perniosis-like) skin lesions caused concern among dermatologists. Exanthems were widely distributed and were primarily located on the trunk. Associated symptoms, latency time, treatment, and prognosis were also carefully summarized. This study reviewed the recently published COVID-19 studies with skin manifestations, which may pave the way for further research. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.



KEYWORDS:

COVID-19; coronavirus; cutaneous manifestations; review; skin


PMID:32383234DOI:10.1111/dth.13528
 
Back
Top Bottom